IF
ZYNE

Ironwood Financial’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Ironwood Financial’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-118
Closed -$1K – 583
2021
Q3 		$1K Hold
118
– – ﹤0.01% 554
2021
Q2 		$1K Hold
118
– – ﹤0.01% 543
2021
Q1 		$1K Buy
+118
New +$535 ﹤0.01% 526

Other funds holding ZYNE

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Ironwood Financial's ZYNE Position: Q4 2021 in Review

Ironwood Financial sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2021, closing a stake of 118 shares — an estimated $1K sold.

Ironwood Financial first reported a position in ZYNE in Q1 2021 and held it in 3 quarters. The position peaked at $1K in Q3 2021. 62 funds tracked by Wall St. Rank hold ZYNE as of Q4 2021.

  • Ironwood Financial reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2021 after selling out during the quarter.
  • Ironwood Financial sold 118 Zynerba Pharmaceuticals, Inc shares in Q4 2021, an estimated $1K.
  • Ironwood Financial first reported a position in Zynerba Pharmaceuticals, Inc in Q1 2021 and held it in 3 quarters.
  • Ironwood Financial's Zynerba Pharmaceuticals, Inc position peaked at $1K in Q3 2021.
  • 62 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2021.

Based on Ironwood Financial's 13F filing for Q4 2021, filed 28 Jan 2022.